Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD)

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 2, 2007, Pages 3-9

  Alonso, Jordi ^a   Lépine, Jean Pierre ^b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY DISORDER; CLINICAL STUDY; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EUROPE; FEMALE; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR;

ADULT; AGED; DISABLED PERSONS; EPIDEMIOLOGIC STUDIES; EUROPE; FEMALE; HEALTH SERVICES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; RISK FACTORS; SAMPLE SIZE;

EID: 33847418020     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Jenkins R, Lewis G, Bebbington P, et al. The National Psychiatric Morbidity Surveys of Great Britain: initial findings from the household survey. Int Rev Psychiatry 2003;15:29-42
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105
3. Jacobi F, Wittchen HU, Holting C, et al. Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res 2002;11:1-18
4. Ayuso-Mateos JL, Vazquez-Barquero JL. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001;179:308-316
5. Bebbington P, Brugha T, Meltzer H, et al. Psychiatric disorder and dysfunction in the UK National Survey of Psychiatric Morbidity. Soc Psychiatry Psychiatr Epidemiol 2000;35:191-197
6. Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry 2000;34:197-205
7. Lindeman S, Hamalainen J, Isometsa E, et al. The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults. Acta Psychiatr Scand 2000;102:178-184
8. Tylee A, Gastpar M, Lepine JP, et al. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 1999;14:139-151
9. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595
10. Lepine JP, Gastpar M, Mendlewicz J, et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19-29
11. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
12. ESEMeD/MHEDEA 2000 investigators. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:8-20
13. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:93-121
14. ESEMeD/MHEDEA 2000 investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:21-27
15. Ware JE, Kosinsiki M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996;34(3):220-233
16. Rehm J, Ustün TB, Saxena S, et al. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Methods Psychiatr Res 1999;8:110-122
17. Paykel ES, Brugha TS, Fryers T. Size and burden of depressive disorders in Europe. Eur Neuropsychopharmacol 2005;15:411-423
18. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627
19. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602
20. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357-376
21. ESEMeD/MHEDEA 2000 investigators. 12-month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:28-37
22. ESEMeD/MHEDEA 2000 investigators. Disability and quality of life impact of mental disorders: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:38-46
23. ESEMeD/MHEDEA 2000 investigators. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:47-54
24. Brugha TS, Bebbington PE, Singleton N, et al. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004;185:378-384